Korro Bio, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Korro Bio, Inc. (KRRO) reported Increase (Decrease) in Prepaid Expense and Other Assets of $345.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-06
- Korro Bio, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $399.00K.
- Korro Bio, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$54.00K, a 108.75% decline year-over-year.
- Korro Bio, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $1.49M.
- Korro Bio, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$256.00K.
- Korro Bio, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $1.67M, a 130.58% increase from fiscal 2024.
- Korro Bio, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $726.00K.
- Korro Bio, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$559.00K, a 2096.43% decline from fiscal 2022.
- Korro Bio, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $28.00K, a 83.82% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $399.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $345.00K 10-Q · filed 2026-08-06 | $1.83M derived: sum of 3 quarters · filed 2026-08-06 | $1.57M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$54.00K 10-Q · filed 2026-05-07 | $1.43M derived: sum of 2 quarters · filed 2026-05-07 | $1.18M derived: sum of 3 quarters · filed 2026-05-07 | $1.00M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $1.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $1.23M derived: sum of 2 quarters · filed 2026-03-12 | $1.06M derived: sum of 3 quarters · filed 2026-08-06 | $1.67M 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | -$256.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$428.00K derived: sum of 2 quarters · filed 2026-08-06 | $189.00K 10-Q · filed 2025-11-12 | $22.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | -$172.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $445.00K 10-Q · filed 2026-08-06 | $278.00K derived: sum of 3 quarters · filed 2026-08-06 | -$221.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $617.00K 10-Q · filed 2026-05-07 | $450.00K derived: sum of 2 quarters · filed 2026-05-07 | -$49.00K derived: sum of 3 quarters · filed 2026-05-07 | $1.05M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | -$167.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$666.00K derived: sum of 2 quarters · filed 2026-03-12 | $436.00K derived: sum of 3 quarters · filed 2026-03-12 | $726.00K 10-K · filed 2026-03-12 | ||||
| 2024-09-30 | -$499.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $603.00K derived: sum of 2 quarters · filed 2025-11-12 | $893.00K 10-Q · filed 2025-11-12 | $320.00K derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $1.39M 10-Q · filed 2025-08-12 | $819.00K derived: sum of 3 quarters · filed 2025-08-12 | $734.00K derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | $290.00K 10-Q · filed 2025-05-07 | -$283.00K derived: sum of 2 quarters · filed 2025-05-07 | -$368.00K derived: sum of 3 quarters · filed 2025-05-07 | -$610.00K derived: sum of 4 quarters · filed 2025-05-07 | ||||
| 2023-12-31 | -$573.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | -$658.00K derived: sum of 2 quarters · filed 2025-03-18 | -$900.00K derived: sum of 3 quarters · filed 2025-03-18 | -$559.00K 10-K · filed 2025-03-18 | ||||
| 2023-09-30 | -$85.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$327.00K derived: sum of 2 quarters · filed 2024-11-12 | $14.00K 10-Q · filed 2024-11-12 | -$3.97M 10-Q · filed 2023-11-02 | $3.23M derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | -$242.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $99.00K 10-Q · filed 2024-08-13 | -$2.50M 10-Q · filed 2023-08-10 | $3.32M derived: sum of 3 quarters · filed 2024-08-13 | $1.76M derived: sum of 4 quarters · filed 2024-08-13 | |||
| 2023-03-31 | $341.00K 10-Q · filed 2024-05-14 | -$2.05M 10-Q · filed 2023-05-12 | $3.56M derived: sum of 2 quarters · filed 2024-05-14 | $2.00M derived: sum of 3 quarters · filed 2024-05-14 | $1.75M derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | $3.22M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $1.66M derived: sum of 2 quarters · filed 2024-03-26 | $1.41M derived: sum of 3 quarters · filed 2024-03-26 | $28.00K 10-K · filed 2024-03-26 | -$681.00K 10-K · filed 2023-03-10 | |||
| 2022-09-30 | -$1.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$1.81M derived: sum of 2 quarters · filed 2023-11-02 | -$3.19M 10-Q · filed 2023-11-02 | -$132.00K derived: sum of 4 quarters · filed 2023-11-02 | ||||
| 2022-06-30 | -$251.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$1.64M 10-Q · filed 2023-08-10 | $1.43M derived: sum of 3 quarters · filed 2023-08-10 | -$215.00K derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | -$1.39M 10-Q · filed 2023-05-12 | $1.68M derived: sum of 2 quarters · filed 2023-05-12 | $36.00K derived: sum of 3 quarters · filed 2023-05-12 | -$876.00K derived: sum of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | $3.06M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | $1.42M derived: sum of 2 quarters · filed 2023-03-10 | $509.00K derived: sum of 3 quarters · filed 2023-03-10 | $173.00K 10-K · filed 2023-03-10 | ||||
| 2021-09-30 | -$1.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$2.55M derived: sum of 2 quarters · filed 2022-11-08 | -$2.89M 10-Q · filed 2022-11-08 | -$1.28M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | -$912.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$1.25M 10-Q · filed 2022-08-09 | $363.00K derived: sum of 3 quarters · filed 2022-08-09 | $430.00K derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | -$336.00K 10-Q · filed 2022-05-04 | $336.00K 10-Q · filed 2021-05-13 | $1.27M derived: sum of 2 quarters · filed 2022-05-04 | $1.34M derived: sum of 3 quarters · filed 2022-05-04 | $537.00K derived: sum of 4 quarters · filed 2022-05-04 | |||
| 2020-12-31 | $1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $1.68M derived: sum of 2 quarters · filed 2022-03-15 | $873.00K derived: sum of 3 quarters · filed 2022-03-15 | $626.00K 10-K · filed 2022-03-15 | ||||
| 2020-09-30 | $67.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$738.00K derived: sum of 2 quarters · filed 2021-11-15 | -$985.00K 10-Q · filed 2021-11-15 | $1.61M derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | -$805.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$1.05M 10-Q · filed 2021-08-12 | $1.55M derived: sum of 3 quarters · filed 2021-08-12 | $1.18M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | -$247.00K 10-Q · filed 2021-05-13 | $2.35M derived: sum of 2 quarters · filed 2021-05-13 | $1.98M derived: sum of 3 quarters · filed 2021-05-13 | |||||
| 2019-12-31 | $2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $2.23M derived: sum of 2 quarters · filed 2021-03-29 | $3.25M 10-K · filed 2021-03-29 | $3.25M 10-K · filed 2020-03-26 | ||||
| 2019-09-30 | -$369.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $653.00K 10-Q · filed 2020-11-16 | $652.00K 10-Q · filed 2019-11-18 | |||||
| 2019-06-30 | $1.02M 10-Q · filed 2020-08-12 | |||||||
| 2018-12-31 | $98.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $727.00K 10-K · filed 2020-03-26 | ||||||
| 2018-09-30 | $629.00K 10-Q · filed 2019-11-18 | |||||||
| 2017-12-31 | -$142.00K 10-K · filed 2020-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |